SCHEMBL25758282

SCHEMBL25758282

COc1ccc(NC(=O)c2cccc(-c3ccnn3C)c2)cc1S(=O)(=O)Nc1c(C)cccc1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 7/20 0.48
HTR2C P28335 2/20 0.48
GAA P10253 3/20 0.48
KDM4E B2RXH2 2/20 0.48
MAPT P10636 2/20 0.48
POLB P06746 2/20 0.48
HCRTR1 O43613 1/20 0.48
HCRTR2 O43614 1/20 0.48
HTT P42858 1/20 0.48
BRD4 O60885 1/20 0.47
BRD3 Q15059 1/20 0.47
KCNH2 Q12809 2/20 0.46
SMN1; SMN2 Q16637 4/20 0.45
ALDH1A1 P00352 2/20 0.45
MAPK1 P28482 2/20 0.45
LMNA P02545 4/20 0.45
HPGD P15428 1/20 0.45
CBLB Q13191 1/20 0.45
CPT1A P50416 1/20 0.44
CPT1B Q92523 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23833422 0.86 CBLB (0.42) HTR2AHTR2CKCNH2CBLBMEN1
SCHEMBL23846480 0.84 GRM4 (0.51) GAAKDM4EMAPTPOLBHCRTR1
SCHEMBL23846619 0.83 ALPL (0.52) GAAKDM4EMAPTPOLBHCRTR1
SCHEMBL23846386 0.82 MEN1 (0.55) GAAKDM4EMAPTPOLBHCRTR1
SCHEMBL25758307 0.82 ABL1 (0.53) GAAKDM4EMAPTPOLBHCRTR1
SCHEMBL25758295 0.82 MAPT (0.52) HTR2AHTR2CGAAKDM4EMAPT
SCHEMBL25755382 0.81 MAPT (0.52) GAAKDM4EMAPTPOLBHCRTR1
SCHEMBL23846445 0.81 HTR2A (0.47) HTR2AHTR2CPOLBKCNH2CBLB
SCHEMBL23846585 0.81 HTR2A (0.47) HTR2AHTR2CGAAKDM4EMAPT
SCHEMBL23846331 0.81 IMPDH2 (0.53) GAAKDM4EMAPTPOLBHCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2023-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174523-A1 BENZENESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF TRAP1, PINK1, TP53BP1 HTR2A 3510/4885HTR2C 3944/4885GAA 1667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.